🇺🇸 FDA
Pipeline program

Placebo will be provided in size and appearance identical to those containing milsaperidone and will be administered orally., Milsaperidone, Milsaperidone, Milsaperidone

VP-VHX-896-3201

Phase 3 small_molecule active

Quick answer

Placebo will be provided in size and appearance identical to those containing milsaperidone and will be administered orally., Milsaperidone, Milsaperidone, Milsaperidone for Major Depressive Disorder is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals Netherlands B.V.
Indication
Major Depressive Disorder
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials